羊水栓塞的诊治

doi:10.3969/j.issn.1004-583X.2016.04.006

临床荟萃 ›› 2016, Vol. 31 ›› Issue (4): 368-372.doi: 10.3969/j.issn.1004-583X.2016.04.006

羊水栓塞的诊治

张洋洋¹, 袁雅冬²

1.承德医学院附属医院呼吸内科,河北承德 067000;
2.河北医科大学第二医院呼吸内科,河北石家庄 050000

收稿日期:2016-01-15 出版日期:2016-04-05 发布日期:2016-04-18
通讯作者: 袁雅冬,Email:yyd1108@126.com
作者简介:张洋洋，女，承德医学院附属医院呼吸内科，主治医师，硕士研究生，解放军医学院在读博士。曾获评承德医学院优秀授课教师。参与并获评中国人民解放军医疗成果奖三等奖1项。研究方向：肺栓塞、急性肺损伤、肺部感染。

Progress in diagnosis and treatment of amniotic fluid embolism

Zhang Yangyang¹, Yuan Yadong²

1.Department of Respiratory Medicine, the Affiliated Hospital of Chengde Medical University, Chengde 067000, China;
2.Department of Respiratory Medicine, the Second Hospital of Hebei Medical University, Shijiazhuang 050000, China

Received:2016-01-15 Online:2016-04-05 Published:2016-04-18
Contact: Yuan Yadong, Email: yyd1108@126.com

摘要/Abstract

摘要： 羊水栓塞是一种罕见、但极为凶险的产科并发症,由羊水物质进入母体循环引起,起病急骤,病死率高。熟悉羊水栓塞的发病机制、临床表现,并进行早期诊断及治疗对降低其病死率有极其重要的价值。

关键词: 栓塞, 羊水, 危险因素, 发病机制, 诊断, 治疗

Abstract: Amniotic fluid embolism is a rare but dreadful obstetric complications with a high maternal mortality, which caused by the transfer of amniotic fluid substances into the maternal circulation. In order to reduce the mortality, it is necessary to be familiar with the pathogenesis and clinical manifestations, and then make early diagnosis and choose the effective treatment.

Key words: embolism,amniotic fluid, risk factors, pathogenesis, diagnosis, therapy

中图分类号:

R714.468

张洋洋, 袁雅冬. 羊水栓塞的诊治[J]. 临床荟萃, 2016, 31(4): 368-372.

Zhang Yangyang, Yuan Yadong. Progress in diagnosis and treatment of amniotic fluid embolism[J]. Clinical Focus, 2016, 31(4): 368-372.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://huicui.hebmu.edu.cn/CN/10.3969/j.issn.1004-583X.2016.04.006

https://huicui.hebmu.edu.cn/CN/Y2016/V31/I4/368

参考文献

[1] Meyer JR. Embolia pulmonary amnio caseosa[J]. Br Med,1926,2:301-303.
[2] Steiner PE,Lushbaugh CC. Landmark article, Oct. 1941: Maternal pulmonary embolism by amniotic fluid as a cause of obstetric shock and unexpected deaths in obstetrics[J]. JAMA,1986,255(16):2187-2203.
[3] 乐杰.妇产科学[M].7版.北京: 人民卫生出版社,2008:208-210.
[4] Busardo FP,Gulino M,Di Luca NM,et al. Not only a clinical nightmare: amniotic fluid embolism in court[J].Curr Pharm Biotechnol,2014,14(14):1195-1200.
[5] Mo X,Feng A,Liu X,et al. Amniotic Fluid Embolism (AFE) in China: are maternal mortality and morbidity preventable [J]. Intractable Rare Dis Res,2014,3(3):97-99.
[6] Knight M,Berg C,Brocklehurst P,et al. Amniotic fluid embolism incidence, risk factors and outcomes: review and recommendations [J]. BMC Pregnancy Childbirth,2012,12(3):7-17.
[7] 中华人民共和国卫生和计划生育员会. 2013年中国卫生和计划生育统计年鉴[M].2版.北京: 中国协和医科大学出版社,2014: 78-80.
[8] Kramer MS,Rouleau J,Baskett TF,et al. Amniotic fluid embolism and medical induction of labour: a retrospective, population-based cohort study [J]. Lancet,2006,368(9545):1444-1448.
[9] Kramer MS,Rouleau J,Liu S,et al. Amniotic fluid embolism: incidence, risk factors, and impact on perinatal outcome [J]. BJOG,2012,119(7):874-879.
[10] Kramer MS,Abenhaim H,Dahhou M, et al. Incidence, risk factors, and consequences of amniotic fluid embolism [J].Paediatr Perinat Ep,2013,27(5):436-441.
[11] Abenhaim HA,Azoulay L,Kramer MS,et al. Incidence and risk factors of amniotic fluid embolisms: a population-based study on 3 million births in the United States [J]. Am J Obstet Gynecol,2008,199(1):49,e1-8.
[12] Knight M,Tuffnell D,Brocklehurst P,et al. Incidence and risk factors for amniotic-fluid embolism [J].Obstet Gynecol,2010,115(5):910-917.
[13] Roberts CL,AlgertCS,KnightM,et al. Amniotic fluid embolism in an Australian population-based cohort [J]. BJOG,2010,117(11):1417-1421.
[14] Fitzpatrick KE, Tuffnell D, Kurinczuk JJ,et al. Incidence, risk factors, management and outcomes of amniotic-fluid embolism: a population-based cohort and nested case-control study [J]. BJOG,2016,123(1):100-109.
[15] Masson RG,Ruggieri J,Siddiqui MM. Amniotic fluid embolism: definitive diagnosis in a survivor [J]. Am Rev Respir Dis,1979,120(1):187-192.
[16] Talbert LM,Adcock DF,Weiss AE,et al. Studies on the pathogenesis of clotting defects during salt induced abortions[J]. Am J Obstet Gynecol,1973,115(5):656-662.
[17] Benson MD. A hypothesis regarding complement activation and amniotic fluid embolism[J]. Medical Hypotheses,2007,68(5):1019-1025.
[18] Chen KB,Chang SS,Tseng YL,et al. Amniotic fluid induces platelet-neutrophil aggregation and neutrophil activation[J]. AJOG,2013,208(4):318,e1-7.
[19] Attwood HD. Fatal pulmonary emboliom by amniotic fluid[J]. J Clin Pathol,1956,9(1):35-46.
[20] Clark SL,HankinsGD,Dudley DA,et al.Amniotic fluid embolism: Analysis of the national registry[J]. Am J Obstet Gynecol,1995,172(4):1158-1167.
[21] Benson MD. Anaphylactoid syndrome of pregnancy[J].Am J Obstet Gynecol,1996,175(3):749.
[22] Benson MD,lindberq RE. Amniotic fluid embolism, anaphylaxis, and tryptase[J].Am J Obstet Gynecol,1996,175(3):737.
[23] Benson MD,Kobayashi H,Silver RK,et al. Immunologic studies in presumed amniotic fluid embolism[J]. Obstet Gynecol,2001,97(4):510-514.
[24] Benson MD. Current concepts of immunology and diagnosis in amniotic fluid embolism[J].Clin Dev Immunol,2012,doi:10.1155/2012/946576.
[25] Tamura N,Kimura S,Farhana M,et al. C1 esterase inhibitor activity in amniotic fluid embolism[J]. Crit Care Med,2014,42(6):1392-1396.
[26] Chen KB,Chang SS,Tseng YL,et al. Amniotic fluid induces platelet neutrophil aggregation and neutrophil activation[J]. Am J Obstet Gynecol,2013,208(4):318-327.
[27] Conde-Agudelo A,Romero R.Amniotic fluid embolism: an evidence-based review[J].Am J Obstet Gynecol,2009,201(5):445,e1-13.
[28] Finesenhi V,Gambassi R,Gherardi M,et al. The diagnosis of amniotic fluid embolism: an immunohistochemical study for the quantification of pulmonary mast cell tryptase[J].Int J Legal Med,1998,111(5):238-243.
[29] Manchanda R,Sriemevan A. Anaphylactoid syndrome caused by amniotic fluid embolism following manual removal of placenta[J]. J Obstet Gynaecol,2005,25(2):201-202.
[30] James CF,Feinglass NG,Menke DM,et al. Massive amniotic fluid embolism: diagnosis aided by emergency transesophageal echocardiography[J]. Int J Obstet Anesth,2004,13(4):279-283.
[31] Saad A,El-Husseini N,Nader GA,et al. Echocardiographically detected mass “intransit” in early amniotic fluid embolism[J].Eur J Echocardiogr,2006,7(4):332-335.
[32] Resnik R,Swartz WH,Plumer MH,et al. Amniotic fluid embolism with survival[J].Obstet Gynecol,1976,47(3):295-298.
[33] Kuhlman K,Hidvegi D,Tamura RK, et al. Is amniotic fluid material in the central circulation of peripartum patients pathologic [J].Am J Perinatol,1985,2(4):295-299.
[34] Clark SL,Pavlova Z,Greenspoon J,et al. Squamous cells in the maternal pulmonary circulation[J]. Am J Obstet Gynecol,1986,154(1):104-106.
[35] Lee W,Ginsburg KA,Cotton DB,et al. Squamous and trophoblastic cells in the maternal pulmonary circulation identified by invasive hemodynamic monitoring during the peripartum period[J]. Am J Obstet Gynecol,1986,155(5):999-1001.
[36] Kanayama N,Yamazaki T,Naruse H,et al. Determining zinc coproporphyrin in maternal plasma--a new method for diagnosing amniotic fluid embolism[J].Clin Chem,1992,38(4):526-529.
[37] Oi H,Kobayashi H,Hirashima Y,et al. Serological and immunohistochemical diagnosis of amniotic fluid embolism[J].SeminThromb Hemost,1998,24(5):479-484.
[38] Kobayashi H,Ohi H,Terao T. A simple, noninvasive, sensitive method for diagnosis of amniotic fluid embolism by monoclonal antibody TKH-2 that recognizes NeuAc alpha 2-6GalNAc[J]. Am J Obstet Gynecol,1993,168(3):848-853.
[39] Stawicki SP,Papadimos TJ. Challenges in managing amniotic fluid embolism: an up-to-date perspective on diagnostic testing with focus on novel biomarkers and avenues for future research[J]. Curr Pharm Biotechnol,2014,14(14):1168-1178.
[40] Sinicina I,Pankratz H,Bise K,et al. Forensic aspects of post-mortem histological detection of amniotic fluid embolism[J].Int J Legal Med,2010,124(1):55-62.
[41] Leighton BL, Wall MH, Lockhart EM, et al. Use of recombinant factor VIIa inpatients with amniotic fluid embolism: a systematic review of case reports[J].Anesthesiology,2011,115(6):1201-1208.
[42] Kanayama N, Tamura N. Amniotic fluid embolism: pathophysiology and new strategies for management[J]. J Obstet Gynaecol Res,2014,40(6):1507-1517.
[43] Tuffnell DJ. United Kingdom amniotic fluid embolism register[J]. BJOG,2005, 112(12):1625-1629.

羊水栓塞的诊治

Progress in diagnosis and treatment of amniotic fluid embolism

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	王奕涵, 秦旭雁, 韩宣泽, 王樱洁, 高菲菲, 陈春红, 张岭楠, 张芳. 利伐沙班用于HASBLED评分≥3分的高龄非瓣膜性心房颤动患者的有效性和安全性[J]. 临床荟萃, 2024, 39(2): 121-124.
[2]	刘蕾, 李明武, 万荣. 肺结核合并肺栓塞患者实验室指标的诊断价值[J]. 临床荟萃, 2024, 39(2): 134-139.
[3]	金鑫, 吴金玲, 尹丽丽. 持续性植物状态促醒机制及治疗研究进展[J]. 临床荟萃, 2024, 39(2): 172-176.
[4]	王琦, 陈宏. 维生素D在支气管哮喘和慢性阻塞性肺疾病治疗中的应用进展[J]. 临床荟萃, 2024, 39(1): 88-91.
[5]	余泽宇, 林希, 陈章华, 杨巍, 陈志敏, 张海. 儿童难治性肺炎支原体肺炎危险因素分析[J]. 临床荟萃, 2024, 39(1): 43-46.
[6]	刘丽丽, 袁宇婷, 赖耿良, 田川, 蓝翔, 叶中绿. 儿童急性淋巴细胞白血病第15天微小残留与预后的关系[J]. 临床荟萃, 2024, 39(1): 47-52.
[7]	崔兰丹, 杨春燕. 脓毒症患者甲状腺激素的变化特点及研究进展[J]. 临床荟萃, 2024, 39(1): 70-74.
[8]	马丽娜, 焦焕利, 曹振华. 慢性非缺血性心功能衰竭合并血栓栓塞及药物治疗研究进展[J]. 临床荟萃, 2024, 39(1): 75-79.
[9]	邹子良, 余海, 王迪, 褚泰运, 李驹, 钱宝堂. 冠状动脉慢性完全闭塞病变介入治疗研究现状[J]. 临床荟萃, 2024, 39(1): 80-83.
[10]	游琪琪, 霍丽娟. 原发性胆汁性胆管炎-自身免疫性肝炎重叠综合征的诊治进展[J]. 临床荟萃, 2024, 39(1): 84-87.
[11]	位增, 曹灵, 佘敦敏, 刘彦, 王艳, 张真稳. 54例2型糖尿病患者合并新型冠状病毒感染的死亡原因分析[J]. 临床荟萃, 2023, 38(9): 806-812.
[12]	赵浩天, 李丽. 肺超声在心脏急重症疾病合并肺水肿中应用的研究进展[J]. 临床荟萃, 2023, 38(9): 832-837.
[13]	王鑫, 张展, 刘铎, 谢萍. 铁缺乏与肺动脉高压相关性的研究进展[J]. 临床荟萃, 2023, 38(9): 838-844.
[14]	陈聪水, 李园, 陈淑芳. 重视儿童胆源性胰腺炎的中西医诊治(附1例分析)[J]. 临床荟萃, 2023, 38(8): 726-730.
[15]	左腾, 王俊祥. 血清阴性类风湿关节炎发病机制的研究进展[J]. 临床荟萃, 2023, 38(8): 753-756.